Clinical Trials Logo

Pre-Cancerous Dysplasia clinical trials

View clinical trials related to Pre-Cancerous Dysplasia.

Filter by:
  • None
  • Page 1

NCT ID: NCT06075264 Recruiting - HPV Infection Clinical Trials

Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)

ART-VIN IIB
Start date: December 6, 2023
Phase: Phase 2
Study type: Interventional

This is a phase II double-blind, placebo-controlled study of artesunate ointment for the treatment of HPV-associated vulvar HSIL (usual type vulvar intraepithelial neoplasia 2/3).

NCT ID: NCT04098744 Recruiting - HPV Infection Clinical Trials

Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

ART-CIN_IIB
Start date: September 9, 2020
Phase: Phase 2
Study type: Interventional

This is a phase II double blind, placebo-controlled, randomized study of Artesunate vaginal inserts for the treatment of women who have cervical high grade intraepithelial neoplasia (CIN2/3).

NCT ID: NCT04000503 Completed - Cervical Cancer Clinical Trials

Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge)

ASPIRE
Start date: August 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this pragmatic cluster randomized control trial is to test the effectiveness of cervical cancer screening follow-up completion using two implementation approaches for self-collected HPV testing in a rural, low-resource setting: 1) community health workers recruiting women door-to-door and 2) community health workers recruiting women at community health meetings. This study will also help to further understand how current patient referral systems are working between health facilities, patient and provider preferences for integrated care and health system related barriers to integrated cervical cancer screening. Hypothesis: More women will receive screening via the community health meeting but the engagement to care (i.e., visual inspection with acetic acid-our main outcome) will be greater in the door-to-door arm.